Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (332)	1/5/2001 12:36:20 PM
From: tuck	Respond to of 1784

Rick, Dr. Nitz was at Sterling Winthrop, which got munched by Sanofi, but with lots of layoffs. So who knows if he's (she's) at Sanofi or elsewhwere. Tried emailing IR at AGNT, cuz I've had that affiliation problem, too, and that may be one way of dealing with it. If they get back to me before Doc Voodoo or td get back to you, I'll let you know. Cheers, Tuck

To: scaram(o)uche who wrote (332)	1/5/2001 8:38:08 PM
From: Dr. Voodoo	Read Replies (2) \| Respond to of 1784

Tracy Deegan and John Porco are at Argonaut and I've spoken to them a couple times. A scifinder search turned up only the one reference on Diane Cebzanov an Denise Pufko. Theodore J. Nitz turned up this and another patent from Viropharma. Preparation of heterocyclyl-substituted methylidynetrisphenol derivatives and related compounds for treating or preventing pneumovirus infection and associated diseases. Nitz, Theodore J.; Pevear, Daniel C. (Viropharma Incorporated, USA). PCT Int. Appl. (1999), V